Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2013  |  Volume : 9  |  Issue : 2  |  Page : 187-192

Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: A meta-analysis


1 Department of Epidemiology and Biostatistics, Ministry of Education Key Lab for Modern Toxicology, School of Public Health; The First Clinical Medical College, Nanjing Medical University, Nanjing 210029, China
2 Department of Epidemiology and Biostatistics, Ministry of Education Key Lab for Modern Toxicology, School of Public Health, Nanjing, China
3 The First Clinical Medical College, Nanjing Medical University, Nanjing 210029, China

Correspondence Address:
Hongxia Ma
Department of Epidemiology and Biostatistics, School of public health, Nanjing Medical University, 140 Hanzhong Road, Nanjing, Jiangsu 210029
China
Login to access the Email id

Source of Support: A project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD),, Conflict of Interest: None


DOI: 10.4103/0973-1482.113345

Rights and Permissions

Introduction: The Xeroderma pigmentosum group D (XPD, also referred to as excision repair cross complementing gene 2, ERCC2) is one of key genes involved in nucleotide excision repair and two potentially functional polymorphisms of XPD (Asp312Asn and Lys751Gln) have been widely investigated in various cancers including prostate cancer. However, the results were conflicting rather than conclusive. Aims: Thus, we conducted a meta-analysis to evaluate the associations between these two polymorphisms of XPD and the risk of prostate cancer. Materials and Methods: An electronic search of PubMed and Embase was conducted to select relevant studies. Studies containing available genotype frequencies of XPD Asp312Asn and Lys751Gln were chosen, and the associations were assessed by pooled odds ratios with 95% confidence intervals. Results: According to PubMed and Embase databases, we identified seven eligible studies from six articles, including 2641 cases and 3259 controls for Asp312Asn and nine eligible studies from eight articles, including 3255 cases and 3654 controls for Lys751Gln. The meta-analysis showed that no overall association was observed between XPD Asp312Asn and prostate cancer risk. However, the significantly increased risk of 312Asp allele was found among Asians and Africans, but it seemed to be protective in Caucasians when stratified by ethnicity. For XPD Lys751Gln, overall findings had implicated null effects. Conclusion: These findings indicated that the Asn allele of XPD Asp312Asn might be a risk-factor for developing prostate cancer among Asian and African men but protective for Caucasian population.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2322    
    Printed45    
    Emailed0    
    PDF Downloaded249    
    Comments [Add]    
    Cited by others 2    

Recommend this journal